Cargando…
Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients
BACKGROUND: Metastasis represents a deadly aspect of any cancer including breast cancer, given its high prevalence; treatment of metastatic breast cancer remains a clinically unmet need, which necessitates the exploration of metastasis suppressor genes (MSGs). KAI-1/CD82 is an important member of MS...
Autores principales: | Latha, Thammineni Krishna, Verma, Ankur, Thakur, Gaurav Kumar, Banerjee, Basudev, Kaur, Navneet, Singh, Usha Rani, Sharma, Sonal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063004/ https://www.ncbi.nlm.nih.gov/pubmed/31759355 http://dx.doi.org/10.31557/APJCP.2019.20.11.3321 |
Ejemplares similares
-
Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
por: Yan, Wei, et al.
Publicado: (2021) -
Organochlorine pesticide exposure as a risk factor for breast cancer in young Indian women: A case–control study
por: Kaur, Navneet, et al.
Publicado: (2019) -
Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
por: Uchida, S, et al.
Publicado: (1999) -
Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
por: WANG, GENGMING, et al.
Publicado: (2015) -
Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1
por: Ordas, Laura, et al.
Publicado: (2021)